|
Hospital
|
Health centres
|
Total
|
---|
Total patients on ART
|
8902 (74%)
|
3102 (26%)
|
12004
|
Gender
| | | |
Male
|
3354 (38%)
|
962 (31%)
|
4316 (36%)
|
Female
|
5548 (62%)
|
2140 (69%)
|
7688 (64%)
|
Median age – IQR
|
34 (29–41)
|
35 (29–42)
|
35 (29–41)
|
WHO stage / CD4
| | | |
WHO Stage 1–2 & CD4>200/mm3
|
193 (2%)
|
18 (0.6%)
|
211 (2%)
|
WHO stage 1–2 & CD4≤200/mm3
|
645 (7%)
|
31 (1%)
|
676 (6%)
|
WHO stage 1–2 & CD4 unknown
|
192 (2%)
|
139 (4%)
|
331 (3%)
|
Stage 3†
|
5581 (63%)
|
2522 (81%)
|
8103 (68%)
|
Stage 4†
|
2291 (26%)
|
392 (13%)
|
2683 (22%)
|
Start year of ART
| | | |
2003
|
391 (100%)
|
NA
|
391
|
2004
|
1058 (100%)
|
NA
|
1058
|
2005
|
1439 (100%)
|
NA
|
1439
|
2006
|
2281 (83%)
|
451 (17%)
|
2732
|
2007
|
2225 (62%)
|
1347 (38%)
|
3572
|
2008
|
1508 (54%)
|
1304 (46%)
|
2812
|
-
† Irrespective of CD4 count.
-
* CD4 counts were not reported separately as 68% of patients followed up in the health centres did not have CD4 counts. These are no longer done on WHO stage 3 and 4 patients, according to the Malawian guidelines.